Moluk, Sapna D.
HRN: 22-11-09 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2022
CO-AMOXICLAV 625MG (TAB)
10/23/2022
10/29/2022
ORAL
625 Mg
BID
SP RMLE
Waiting Final Action